Literature DB >> 6693771

Natural release of covalently bound C3b from cell surfaces and the study of this phenomenon in the fluid-phase system.

Y P Venkatesh, T M Minich, S K Law, R P Levine.   

Abstract

Covalently bound C3b is released from cell surfaces (EAC1423 and zymosan-C3b) on incubation under physiologic conditions. The release of C3b from cell surfaces occurs by the cleavage of the covalent bond. Sodium dodecyl sulfate (SDS) abolishes the release, thereby indicating the requirement of the native structure of C3b in this process. The phenomenon of release of C3b from cell surfaces has also been observed in the fluid-phase system by using C3b-[3H]glycerol. The kinetics of the release of [3H]glycerol from C3b-[3H]glycerol were studied at 37 degrees C in 0.15 M phosphate buffer, pH 7.4. The first-order rate constant was found to be 0.028 +/- 0.003 hr-1. The release does not take place in either 8 M urea or 6 M guanidine hydrochloride, at pH 7.4. Under alkaline conditions, the rate of release is unaffected in the presence of SDS, indicating that the release in this pH range is not dependent on the native structure of the protein. From the Arrhenius plot in the temperature range 18 to 37 degrees C, an apparent activation energy for the hydrolysis reaction of 21.2 kcal/mol was calculated. The release phenomenon is exclusive for ester-linked complexes, as inferred by the absence of release of [3H]threonine from C3b-[3H]threonine, wherein the linkage is of the amide type. The presence or absence of the C3a portion of the molecule has no effect on the rate of release. The modification of the -SH group of C3i-/C3b-[3H]glycerol alters the rate of hydrolysis of the ester bond between C3i/C3b and [3H]glycerol. Protease inhibitors (PMSF, benzamidine HCl, and DFP) do not alter the rate of release, indicating that the hydrolysis reaction is not due to trace amounts of contaminating proteases. Thus, it appears that some chemical group(s) of C3i/C3b is (are) involved in the intramolecular hydrolysis of the ester bond between C3i/C3b and small molecules. This phenomenon may play an important role in the release of C3b from receptive surfaces once the biologic functions that require covalently bound C3b have been mediated.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693771

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood.

Authors:  Hanmant Gaikwad; Yue Li; Geoffrey Gifford; Ernest Groman; Nirmal K Banda; Laura Saba; Robert Scheinman; Guankui Wang; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2020-06-29       Impact factor: 4.774

2.  The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.

Authors:  Lisa A Lewis; Matthew Carter; Sanjay Ram
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

3.  The pathogenesis of hyaline arteriolosclerosis.

Authors:  C N Gamble
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

4.  Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

Authors:  Fangfang Chen; Guankui Wang; James I Griffin; Barbara Brenneman; Nirmal K Banda; V Michael Holers; Donald S Backos; LinPing Wu; Seyed Moein Moghimi; Dmitri Simberg
Journal:  Nat Nanotechnol       Date:  2016-12-19       Impact factor: 39.213

5.  Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement.

Authors:  Sanjay Ram; Lisa A Lewis; Sarika Agarwal
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

6.  Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.

Authors:  A Sahu; T R Kozel; M K Pangburn
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

7.  Activation of the human complement alternative pathway by Listeria monocytogenes: evidence for direct binding and proteolysis of the C3 component on bacteria.

Authors:  J Croize; J Arvieux; P Berche; M G Colomb
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

8.  Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937.

Authors:  C M Maison; C L Villiers; M G Colomb
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

9.  Functional properties of membrane cofactor protein of complement.

Authors:  T Seya; J P Atkinson
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

10.  Complement binding by two developmental stages of Leishmania major promastigotes varying in expression of a surface lipophosphoglycan.

Authors:  S M Puentes; D L Sacks; R P da Silva; K A Joiner
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.